Scientists are exploring leading-edge technologies that could transform how cancer is studied, detected and treated by ...

A new review by researchers at Oregon Health & Science University’s Knight Cancer Institute and other universities highlights how advances in New Approach Methodologies and tissue engineering are ...

Oncoinvent ASA has completed a merger, resulting in the allocation of consideration shares to former shareholders, including primary insiders. This strategic move is expected to strengthen ...

Many cancer patients overlook crucial early warning signs, mistaking them for everyday issues. Oncologist Dr. Anchal Aggarwal ...

Texas A&M researchers have unlocked a new way to harness astatine-211, a rare and powerful isotope that may revolutionize ...

Researchers at the University of São Paulo have discovered a molecule in arachnid venom that behaves like a commonly used chemotherapy drug for treating the disease, with preliminary findings ...

The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...

Cancer patients who got an mRNA COVID vaccine within a few months of their immunotherapy lived longer than those who did not, health records show.

University of Wisconsin’s Carbone Cancer Center recently announced a partnership with TAE Life Sciences, a company that ...

The observation that mRNA vaccines can sensitize tumors to immunotherapy has researchers eager to test how mRNA’s ability to activate the immune system could be harnessed in oncology.